Dolby Laboratories Inc
NYSE:DLB
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
66.4711
86.89
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Dolby Laboratories Inc
Wall Street
Price Targets
DLB Price Targets Summary
Dolby Laboratories Inc
According to Wall Street analysts, the average 1-year price target for
DLB
is 102 USD
with a low forecast of 101 USD and a high forecast of 105 USD.
DLB Last Price Targets
Dolby Laboratories Inc
The latest public price target was made on Feb 3, 2023 by
Unknown Analyst
from
Rosenblatt Securities
,
who expects
DLB
stock to
rise by 16%
over the next 12 months.
You can read more about this price target by viewing
the article on Benzinga.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Unknown Analyst
Rosenblatt Securities
|
90
USD
Upside 16% |
1 year ago
Feb 3, 2023
|
Rosenblatt Maintains Buy on Dolby Laboratories, Raises Price Target to $90
Benzinga
|
Operating Income
Forecast
Operating Income Estimate
Dolby Laboratories Inc
For the last 8 years the
compound annual growth rate for
Dolby Laboratories Inc's operating income is
2%.
The projected
CAGR
for the next 3 years is
12%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DLB's stock price target?
Price Target
102
USD
According to Wall Street analysts, the average 1-year price target for
DLB
is 102 USD
with a low forecast of 101 USD and a high forecast of 105 USD.
What is Dolby Laboratories Inc's Revenue forecast?
Projected CAGR
6%
For the last 8 years the
compound annual growth rate for
Dolby Laboratories Inc's revenue is
3%.
The projected
CAGR
for the next 3 years is
6%.
What is Dolby Laboratories Inc's Operating Income forecast?
Projected CAGR
12%
For the last 8 years the
compound annual growth rate for
Dolby Laboratories Inc's operating income is
2%.
The projected
CAGR
for the next 3 years is
12%.
What is Dolby Laboratories Inc's Net Income forecast?
Projected CAGR
22%
For the last 8 years the
compound annual growth rate for
Dolby Laboratories Inc's net income is
4%.
The projected
CAGR
for the next 3 years is
22%.
You don't have any saved screeners yet
